Localized forms of scleroderma, including morphea, linear scleroderma, and eosinophilic fasciitis

Current Opinion in Rheumatology

Volumn 8, Issue 5, 1996, Pages 473-476

  Nelson, Audrey M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CD23 ANTIGEN;

ARTICLE; BORRELIA BURGDORFERI; EOSINOPHILIC FASCIITIS; MORBIDITY; MORPHEA; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCLERODERMA;

EID: 0029826381     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199609000-00014     Document Type: Article

References (23)

1. Peterson LS, Nelson AM, Su WPD: Classification of morphea (linear scleroderma). Mayo Clin Proc 1995, 70:1068-1076. A review of morphea (localized scleroderma) and a revised classification into five groups-plaque, generalized, bullous, linear, and deep-is presented. The clinical features of each subtype are described.
2. Kencka D, Blaszczyk M, Jablonska: Atrophoderma Pasini-Pierinl is a primary atrophic abortive morphea. Dermatology 1995, 190:203-206.
3. Izumi T, Tajima S: A case of linear type of lichen sclerosus et atrophicus? J Dermatol 1995, 22:279-282.
4. 1. Int J Dermatol 1995, 34:201-202.
5. Sato S, Fujimoto M, Kikuchi K, Ihn H, Tamaki K, Takehara K: Elevated soluble CD23 levels In the sera from patients with localized scleroderma. Arch Dermatol Res 1996, 288:74-78. Elevated levels of sCD23, which is closely related to B cell activation, were found to significantly correlate with severity of localized scleroderma.
6. Skobieranda K, Helm KF: Decreased expression of the human progenltor cell antigen (CD34) In morphea. Am J Dermatopathol 1995, 17:471-475.
7. Takasaki S, Fujiwara S, Shinkai H, Ooshima A: Human type VI collagen: purification from human subcutaneous fat tissue and an immunohlstochemical study of morphea and systemic sclerosis. J Dermatol 1995, 22:480-485.
8. Aberer E, Neumann R, Stanek G: Is localized scleroderma a Borrelia infection? [letter]. Lancet 1985, II:278.
9. Dillon WI, Saed GM, Fivenson DP: Borrelia burgdorferi DNA Is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America. J Am Acad Dermatol 1995, 33:617-620.
10. Fan W, Leonardi CL, Penneys NS: Absence of Borrelia burgdorferi In patients with localized scleroderma (morphea). J Am Acad Dermatol 1995, 33:682-684.
11. Wienecke R, Schlupen EM, Zochling N, Neubert U, Meurer M, Volkenandt M: No evidence for Borrelia burgdorferi-specific DNA In lesions of localized scleroderma. J Invest Dermatol 1995, 104:23-26.
12. Hashimoto Y, Takahashi H, Matsuo S, Hirai K, Takemori N, Nakao M, Miyamoto K, Iizuka H: Polymerase chain reaction of Borralia burgdorferi flagellin gene in Shulman syndrome. Dermatology 1996, 192:136-139.
13. Buechner SA, Lautenschlager S, Itin P, Bircher A, Erb P: Lymphoprollferative responses to Borralia burgdorferi in patients with erythema mlgrans, acrodermatltis chronica atrophicans, lymphadenosis benigna cutis, and morphea. Arch Dermatol 1995, 131:673-677.
14. Rosenberg AM, Uziel Y, Krafchik BR, Hauta SA, Prokopchuk PA, Silverman ED, Laxer RM: Antinuclear antibodies in children with localized scleroderma. J Rheumatol 1995, 22:2337-2343. The ANA profiles of 27 children with localized scleroderma are reported. ANA are frequently present in such children and most often showed specificity for denatured DNA or high morbidity group proteins.
15. Fujimoto M, Sato S, Ihn H, Kikuchi K, Yamada N, Takehara K: Serum aldolase level Is a useful indicator of disease activity In eosinophllic fasciitls. J Rheumatol 1995, 22:563-565.
16. Song YW, Kim HA, Song KY: Eosinophilic fasciitls with occlusive vasculitls and gangrene of the finger. J Rheumatol 1995, 22:356-359.
17. Waale WHE, Bravenboer B: Total hemlatrophy as a rare presentation of linear scleroderma. Neth J Med 1995, 45:117-120.
18. Finkelstein E, Amichai B, Metzker A: Coexistence of vltillgo and morphea: a case report and review of the literature. J Dermatol 1995, 22:351-353.
19. Campbell WW, Bajandas FJ: Restrictive ophthalmology associated with linear scleroderma. J Neuro-Ophthalmol 1995, 15:95-97.
20. Chung MH, Sum J, Morrell MJ, Horoupian DS: Intracerebral involvement in scleroderma en coup de sabre: report of a case with neuropathologic findings. Ann Neurol 1995, 37:679-681. A report of histologic examination of brain tissue removed from a patient with long-standing en coup de sabre and seizures.
21. Pupillo G, Andermann F, Dubeau F: Linear scleroderma and intractable epilepsy: neuropathologic evidence for a chronic Inflammatory process. Ann Neurol 1996, 39:277-278.
22. Takeda S, Takazakura E, Fukui Y: Tubulointerstitlal nephritis in a patient with eosinophllic fasciitls and IgA nephropathy. Nephron 1995, 69:314-317.
23. Janzen L, Jeffery JR, Gough J, Chalmers IM: Response to methotrexate in a patient with idiopathic eosinophilic fasclltis, morphea, IgM hyper-gamma-globullnemla, and renal Involvement J Rheumatol 1995, 22:1967-1970.